1～6 item / All 6 items
From bench scale to commercial scale.
Comprehensive solutions for advanced medical care: ■ Plasmids ■ iPS cells ■ Virus vectors ■ Cell therapy (autologous, allogeneic) ■ mRNA ■ Process development and analytical services ■ Clinical and commercial manufacturing ■ Clinical supply services
![[Research Material] The Global Market for Stem Cell Treatment of Hair Loss](https://image.mono.ipros.com/public/product/image/dd2/2000843299/IPROS38016913673640483054.jpeg?w=280&h=280)
Global Market for Stem Cell Treatment of Hair Loss: Alopecia Areata, Total Alopecia, Universal Alopecia, Hospitals, Clinics, Others
This research report (Global Stem Cell Alopecia Treatment Market) investigates and analyzes the current status and future outlook of the global market for alopecia stem cell treatments over the next five years. It includes information on the overview of the global alopecia stem cell treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the alopecia stem cell treatment market focus on alopecia areata, totalis, and universalis, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for alopecia stem cell treatments. It also includes the market share of major companies in alopecia stem cell treatment, product and business overviews, and sales performance.
![[Research Material] The Global Market for Stem Cell Therapy in Osteoarthritis](https://image.mono.ipros.com/public/product/image/4ca/2001474215/IPROS16850556081008009696.jpeg?w=280&h=280)
Global Market for Stem Cell Therapy in Osteoarthritis: Monotherapy, Combination Therapy, Osteoarthritis (details unknown), Osteoarthritis of the Knee, Shoulder Osteoarthritis, ...
This research report (Global Stem Cell Therapy for Osteoarthritis Market) investigates and analyzes the current status and outlook for the global market of stem cell therapy for osteoarthritis over the next five years. It includes information on the overview of the global stem cell therapy market for osteoarthritis, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for stem cell therapy in osteoarthritis by type include monotherapy and combination therapy, while the segments by application target osteoarthritis (details unknown), osteoarthritis of the knee, shoulder osteoarthritis, and hip osteoarthritis. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for stem cell therapy in osteoarthritis. It also includes the market share of major companies in the stem cell therapy market for osteoarthritis, product and business overviews, and sales performance.
![[Research Material] Global Market for Allogeneic Stem Cell Therapy](https://image.mono.ipros.com/public/product/image/96a/2001481405/IPROS39323025721656457628.jpeg?w=280&h=280)
World Market for Allogeneic Stem Cell Therapy: Adult Stem Cell Therapy, Human Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Others, Musculoskeletal Disorders, Wounds & Injuries, ...
This research report (Global Allogeneic Stem Cell Therapy Market) investigates and analyzes the current status and outlook for the global market of allogeneic stem cell therapy over the next five years. It includes information on the overview of the global allogeneic stem cell therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include adult stem cell therapy, human embryonic stem cell therapy, induced pluripotent stem cell therapy, and others, while the segments by application focus on musculoskeletal disorders, wounds & injuries, cardiovascular diseases, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for allogeneic stem cell therapy. It also includes the market share of major companies in allogeneic stem cell therapy, product and business overviews, and sales performance.
![[Research Material] The Global Market for Canine Stem Cell Therapy](https://image.mono.ipros.com/public/product/image/497/2000834963/IPROS85379955378536154341.jpeg?w=280&h=280)
World Market for Canine Stem Cell Therapy: Allogeneic Stem Cells, Autologous Stem Cells, Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes
This research report (Global Canine Stem Cell Therapy Market) investigates and analyzes the current state and outlook for the global market of canine stem cell therapy over the next five years. It includes information on the overview of the global canine stem cell therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the canine stem cell therapy market focus on allogeneic stem cells and autologous stem cells, while the segments by application target veterinary hospitals, veterinary clinics, and veterinary research institutes. The regional segments calculate the market size for canine stem cell therapy by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in canine stem cell therapy, product and business overviews, and sales performance.
![[Research Material] The Global Market for Natural Killer Cell Therapy](https://image.mono.ipros.com/public/product/image/f62/2001476635/IPROS58376047347083402938.jpeg?w=280&h=280)
Global Market for Natural Killer Cell Therapy: NK Cell Therapy, NK Cell-Directed Antibodies, Research Centers, Institutes, Hospitals, and Others
This research report (Global Natural Killer Cells Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for natural killer cell therapies over the next five years. It includes information on the overview of the global natural killer cell therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the natural killer cell therapy market focus on NK cell therapies and NK cell-targeted antibodies, while the segments by application target research centers, laboratories, hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for natural killer cell therapies. It also includes the market share of major companies in natural killer cell therapies, product and business overviews, and sales performance.
